Therapeutic Hypothermia After Cardiac Arrest

John McPherson

TCT 2024 Insights: Insights from the DanGer Shock and ECLS-Shock Tri…

TCT 2024 Insights

G. Tarantini

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

High-Risk Cardiac Surgery and Pre-Op Optimization with Impella Base …

St. Louis Shock & Heart Failure Symposium 2022

J. Leidenfrost

Heart Failure with Preserved Ejection Fraction: Current Perspectives…

American College of Cardiology

S. Shah

The Past, Present and Future of the Total Artificial Heart

The Texas Heart Institute

W. Cohn, O. Frazier

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

How to Detect and Treat Heart Failure with Preserved Ejection Fracti…

Houston Methodist DeBakey Heart and Vascular Center

Extended Anticoagulation for VTE

Jeffrey Weitz

The Other Option for Hemodynamic Support in High Risk PCI

Joseph Thomas

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

American Heart & Vascular Institute

M. Kittleson

ISCHEMIA Trial: Are We Overusing Cardiac Stents? Is Revascularizatio…

American Heart & Vascular Institute

B. Reddy